BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Offering Details
Offer of shares of common stock through an underwritten public offering.
Use of Proceeds
Intend to use net proceeds to purchase gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
- BioSig Technologies aims to enhance its financial position by offering shares of common stock.
- The company's investment policy includes purchasing gold bullion with the net proceeds from the offering.
BioSig's intention to raise capital through a public offering signifies strategic financial planning for future growth and development in the medical device technology sector.